L613-0320 Screening compound: N-butyl-1-[4-(3-chlorobenzamido)benzoyl]pyrrolidine-2-carboxamide

L613-0320 Screening compound: N-butyl-1-[4-(3-chlorobenzamido)benzoyl]pyrrolidine-2-carboxamide
L613-0320 Screening compound: N-butyl-1-[4-(3-chlorobenzamido)benzoyl]pyrrolidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L613-0320
N-butyl-1-[4-(3-chlorobenzamido)benzoyl]pyrrolidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L613-0320

Molecular Formula

C23H26ClN3O3 (C23 H26 ClN3 O3)

Compound Name

N-butyl-1-[4-(3-chlorobenzamido)benzoyl]pyrrolidine-2-carboxamide

IUPAC name

N-butyl-1-[4-(3-chlorobenzamido)benzoyl]pyrrolidine-2-carboxamide

SMILES

CCCCNC(C(CCC1)N1C(c(cc1)ccc1NC(c1cccc(Cl)c1)=O)=O)=O

InChI

InChI=1S/C23H26ClN3O3/c1-2-3-13-25-22(29)20-8-5-14-27(20)23(30)16-9-11-19(12-10-16)26-21(28)17-6-4-7-18(24)15-17/h4,6-7,9-12,15,20H,2-3,5,8,13-14H2,1H3,(H,25,29)(H,26,28)/t20-/m0/s1

InChI Key

KUYYNTMRAJKZKK-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27466024

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.93

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.763

Distribution Coefficient, logD

3.687

Water Solubility, LogSw

-4.21

Polar Surface Area

64.564

Acid Dissociation Constant (pKa)

8.12

Base Dissociation Constant (pKb)

0.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

34.80

L613-0320 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Neuropeptide S Library (2850 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Nervous system
Targets:
  • Kinases
  • Proteases
  • GPCR
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L613-0320 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L613-0320?
Check Price and Availability of L613-0320, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L613-0320 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L613-0320
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L613-0320
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L613-0320 available by request